Strategic Partnerships

Building smarter relationships.

We work better when we work together. That’s why our Strategic Partnerships enable our biopharma partners to improve their clinical development for all. Our decades of work in this area and global network mean we understand how to help you make the most difference.

Strategic Partnerships can help biopharmaceutical companies:

  • Leverage overhead and infrastructure
  • Complement internal knowledge with external expertise
  • Improve the predictability of their R&D efforts
  • Rapidly expand global reach
  • Increase operational efficiencies
  • Streamline the development process

Positioning Emerging BioPharma for Investors

Read our report, Positioning Emerging BioPharma for Investors, and learn more about essential criteria biopharmaceutical investors seek when evaluating compounds and companies. DOWNLOAD HERE. 

The Value of Building and Implementing Strategic Partnerships in Japan

Hear from Parexel expert Josh Schultz, on the value of building and implementing Strategic Partnerships in Japan, including reduced cost, speed and ability to reduce oversight. CLICK HERE. 

The State of CRO and Sponsor Relationships

Applied Clinical Trials magazine features Parexel's 2013 [LK1] Strategic Partnership report in an article by Editor-in-Chief Lisa Henderson titled, “The State of CRO and Sponsor Relationships.” CLICK HERE.

Maximizing the Value of CRO Relationships

Learn more about how open collaboration, commitment, and mutually agreed upon goals will accelerate the value of CRO alliances. CLICK HERE.

Explore Strategic Partnerships

All Solutions

CLINICAL RESEARCH

Early Phase Services

Your journey from new molecule to new medicine starts with appropriate subjects, world class facilities, and more timely results.

Clinical Trial Supplies & Logistics

To get everything from A to B when it needs to be our logistics specialists use industry-leading supply chain intelligence developed through deep understanding of the demands of development.

Phase II-III Services

From proof-of-concept through regulatory submission, we help smooth and streamline every step.

Positioning Emerging BioPharma for Investors

Read our report, Positioning Emerging BioPharma for Investors, and learn more about essential criteria biopharmaceutical investors seek when evaluating compounds and companies.

DOWNLOAD HERE

The Value of Building and Implementing Strategic Partnerships in Japan

Hear from PAREXEL expert Josh Schultz, on the value of building and implementing Strategic Partnerships in Japan, including reduced cost, speed and ability to reduced cost, speed and ability to reduce oversight. CLICK HERE

The State of CRO and Sponsor Relationships

Applied Clinical Trials magazine features PAREXEL’s 2013 Strategic Partnership report in an article by Editor-in-Chief Lisa Henderson titled, “The State of CRO and Sponsor Relationships

CLICK HERE

Maximizing the Value of CRO Relationships

Learn more about how open collaboration, commitment and mutually agreed upon goals will accelerate the value of CRO alliances.

CLICK HERE

We are always available for a conversation.

*  

We are always available for a conversation.

Submitting...

Communication Preference

Communication Preference